Caret Pharma has entered into an agreement with Moberg Pharma AB to acquire the assets of Fiber Choice, a line of dietary supplements containing 100% natural, prebiotic fiber.
Fiber Choice will be marketed by IM HealthScience, a subsidiary of Caret Group in the research, development and marketing of nonprescription products for the dietary management of digestive disorders. The Fiber Choice acquisition comes at a time of strong growth for IM HealthScience, driven by rapid medical and consumer acceptance of its state-of-the-art medical foods IBgard (for Irritable Bowel Syndrome) and FDgard (for Functional Dyspepsia). Fiber Choice will be an important addition to the company's digestive health product portfolio.
"We are pleased to welcome Fiber Choice to our family of companies. In a time of consumer empowerment and rising healthcare costs, people are taking a more active role in managing their own health and wellness,” Fred Hassan, Founder and Chairman of Caret Group and former Chairman and CEO of Pharmacia and Schering-Plough, said. “We believe Fiber Choice offers these consumers and their healthcare providers an important option."